A Follow-up Study of Subjects With Type 1 Gaucher Disease Who Previously Received AVR-RD-02
Condition: Type 1 Gaucher Disease Intervention: Other: Safety and efficacy assessments Sponsor: AvroBio Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials
A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy
Condition: Gaucher Disease Intervention: Drug: Velaglucerase alfa Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials